Pals Card
Pals Card
ASSOCIATION
Heart ofCRITICAL-CARE
Association® NURSES
PALS
Vital Signs in Children
Respiratory Rate
Heart Rate (per minute) (breaths/min)*
Sleeping Age Rate
Age Awake Rate Rate Infant 30 to 60
Newborn to 3 months 85 to 205 80 to 160 Toddler 24 to 40
3 months to 2 years 100 to 190 75 to 160 Preschooler 22 to 34
2 to 10 years 60 to 140 60 to 90 School-aged child 18 to 30
>10 years 60 to 100 60 to 90 Adolescent 12 to 16
Recommendations
Component
Adults Children Infants
No breathing
or no normal
Recognition No breathing or only gasping
breathing
(ie, only gasping)
Compression
At least 100/min
rate
At least At least
At least 1 1
Compression /3 AP diameter /3 AP diameter
2 inches 1
depth About 2 inches About 1 /2 inches
(5 cm)
(5 cm) (4 cm)
Compression- 30:2
to-ventilation Single rescuer
30:2
ratio (until
1 or 2 rescuers 15:2
advanced
airway placed) 2 rescuers
Scvo2 >70%, low Scvo2 <70%, normal Scvo2 <70%, low BP and
BP ("warm shock") BP but poor perfusion poor perfusion ("cold shock")
Additional fluid Transfuse to Hgb >10 g/dL Transfuse to Hgb >10 g/dL
boluses Optimize arterial oxygen Optimize arterial oxygen
Norepinephrine saturation saturation
vasopressin Additional fluid boluses Additional fluid boluses
Consider milrinone or Consider epinephrine
nitroprusside or dobutamine +
Consider dobutamine norepinephrine
Modified from Brierley J, Carcillo JA, Choong K, et al. Crit Care Med. 2009;37(2):666-688.
Drugs Used in PALS
Drug Indications/Dosages
Adenosine SVT
0.1 mg/kg IV/IO rapid push (max 6 mg), second dose 0.2 mg/kg IV/IO rapid push
(max 12 mg)
Albumin Shock, trauma, burns
0.5 to 1 g/kg (10 to 20 mL/kg of 5% solution) IV/IO rapid infusion
Albuterol Asthma, anaphylaxis (bronchospasm), hyperkalemia
MDI: 4 to 8 puffs via inhalation q 20 minutes PRN with spacer (OR ET if intubated)
Nebulizer: 2.5 mg/dose (wt <20 kg) OR 5 mg/dose (wt>20 kg) via inhalation q
20 minutes PRN
Continuous nebulizer: 0.5 mg/kg per hour via inhalation (max 20 mg/h)
Amiodarone SVT, VT (with pulses)
5 mg/kg IV/IO load over 20 to 60 minutes (max 300 mg), repeat to daily max 15 mg/kg
(2.2 g in adolescents)
Pulseless arrest (ie, VF/pulseless VT)
5 mg/kg IV/IO bolus (max 300 mg), repeat to daily max 15 mg/kg (2.2 g in adolescents)
Atropine sulfate Bradycardia (symptomatic)
0.02 mg/kg IV/IO (min dose 0.1 mg, max single dose child 0.5 mg, max single dose
adolescent 1 mg), may repeat dose once, max total dose child 1 mg, max total dose
adolescent 3 mg
0.04 to 0.06 mg/kg ET
Toxins/overdose (eg, organophosphate, carbamate)
<12 years: 0.02 to 0.05 mg/kg IV/IO initially, then repeat IV/IO q 20 to 30 minutes
until muscarinic symptoms reverse
>12 years: 2 mg IV/IO initially, then 1 to 2 mg IV/IO q 20 to 30 minutes until
muscarinic symptoms reverse
Calcium Hypocalcemia, hyperkalemia, hypermagnesemia, calcium channel blocker overdose
chloride 10% 20 mg/kg (0.2 mL/kg) IV/IO slow push during arrest, repeat PRN
Dexamethasone Croup
0.6 mg/kg PO/IM/IV (max 16 mg)
Dextrose Hypoglycemia
(glucose) 0.5 to 1 g/kg IV/IO (D25 W 2 to 4 mL/kg; D10W 5 to 10 mL/kg)
Diphen- Anaphylactic shock
hydramine 1 to 2 mg/kg IV/IO/IM q 4 to 6 hours (max single dose 50 mg)
Dobutamine Congestive heart failure, cardiogenic shock
2 to 20 mcg/kg per minute IV/IO infusion; titrate to desired effect
Dopamine Cardiogenic shock, distributive shock
2 to 20 mcg/kg per minute IV/IO infusion; titrate to desired effect
Epinephrine Pulseless arrest, bradycardia (symptomatic)
0.01 mg/kg (0.1 mL/kg of 1:10 000 standard concentration) IV/IO q 3 to 5 minutes
(max single dose 1 mg)
0.1 mg/kg (0.1 mL/kg of 1:1000 high concentration) ET q 3 to 5 minutes
Hypotensive shock
0.1 to 1 mcg/kg per minute IV/IO infusion (consider higher doses if needed)
Anaphylaxis
IM autoinjector 0.3 mg (for patient weighing >30 kg) or IM junior autoinjector 0.15 mg
(for patient weighing 10 to 30 kg)
0.01 mg/kg (0.01 mL/kg of 1:1000 high concentration) IM q 15 minutes PRN (max
single dose 0.3 mg)
0.01 mg/kg (0.1 mL/kg of 1:10 000 standard concentration) IV/IO q 3 to 5 minutes
(max single dose 1 mg) if hypotensive
0.1 to 1 mcg/kg per minute IV/IO infusion if hypotension persists despite fluids and
IM injection
Asthma
0.01 mg/kg (0.01 mL/kg) 1:1000 subcutaneously q 15 minutes (max 0.3 mg or 0.3 mL)
Croup
0.25 to 0.5 mg racemic solution (2.25%) mixed in 3 mL NS via inhalation
3 mL of 1:1000 epinephrine mixed with 3 mL NS (which yields 0.25 mL racemic
epinephrine solution) via inhalation
Drugs Used in PALS (continued)
Drug Indications/Dosages
Etomidate RSI
0.2 to 0.4 mg/kg IV/IO infused over 30 to 60 seconds (max 20 mg) will produce rapid
sedation that lasts for 10 to 15 minutes
Hydrocortisone Adrenal insufficiency
2 mg/kg IV bolus (max 100 mg)
Ipratropium Asthma
bromide 250 to 500 mcg via inhalation q 20 minutes PRN x 3 doses
Lidocaine VF/pulseless VT, wide-complex tachycardia (with pulses)
1 mg/kg IV/IO bolus
Maintenance: 20 to 50 mcg/kg per minute IV/IO infusion (repeat bolus dose if
infusion initiated >15 minutes after initial bolus)
2 to 3 mg/kg ET
Magnesium Asthma (refractory status asthmaticus), torsades de pointes, hypomagnesemia
sulfate 25 to 50 mg/kg IV/IO bolus (max 2 g) (pulseless VT) OR over 10 to 20 minutes
(VT with pulses) OR slow infusion over 15 to 30 minutes (status asthmaticus)
Methyl- Asthma (status asthmaticus), anaphylactic shock
prednisolone Load: 2 mg/kg IV/IO/IM (max 60 mg); only use acetate salt IM
Maintenance: 0.5 mg/kg IV/IO q 6 hours (max 120 mg/d)
Milrinone Myocardial dysfunction and increased SVR/PVR
Loading dose: 50 mcg/kg IV/IO over 10 to 60 minutes followed by 0.25 to
0.75 mcg/kg per minute IV/IO infusion
Naloxone Narcotic (opiate) reversal
Total reversal required (for narcotic toxicity secondary to overdose): 0.1 mg/kg
IV/IO/IM/subcutaneous bolus q 2 minutes PRN (max 2 mg)
Total reversal not required (eg, for respiratory depression associated with therapeutic
narcotic use): 1 to 5 mcg/kg IV/IO/IM/subcutaneously; titrate to desired effect
Maintain reversal: 0.002 to 0.16 mg/kg per hour IV/IO infusion
Nitroglycerin Congestive heart failure, cardiogenic shock
Initiate at 0.25 to 0.5 mcg/kg per minute IV/IO infusion; titrate by 1 mcg/kg per
minute q 15 to 20 minutes as tolerated. Typical dose range 1 to 5 mcg/kg per
minute q 15 to 20 minutes as tolerated. Typical dose range 1 to 5 mcg/kg per
In adolescents, start with 5 to 10 mcg per minute (not per kilogram per minute) and
increase to max 200 mcg per minute
Nitroprusside Cardiogenic shock (ie, associated with high SVR), severe hypertension
0.3 to 1 mcg/kg per minute initial dose; then titrate up to 8 mcg/kg per minute as needed
Norepinephrine Hypotensive (usually distributive) shock (ie, low SVR and fluid refractory)
0.1 to 2 mcg/kg per minute IV/IO infusion; titrate to desired effect
Procainamide SVT, atrial flutter, VT (with pulses)
15 mg/kg IV/IO load over 30 to 60 minutes (do not use routinely with amiodarone)
Prostaglandin Ductal-dependent congenital heart disease (all forms)
E1 (PGE1) 0.05 to 0.1 mcg/kg per minute IV/IO infusion initially, then 0.01 to 0.05 mcg/kg per
minute IV/IO
Sodium Metabolic acidosis (severe), hyperkalemia
bicarbonate 1 mEq/kg IV/IO slow bolus
Sodium channel blocker overdose (eg, tricyclic antidepressant)
1 to 2 mEq/kg IV/IO bolus until serum pH is >7.45 (7.50 to 7.55 for severe poisoning)
followed by IV/IO infusion of 150 mEq NaHCO3/L solution titrated to maintain alkalosis
Terbutaline Asthma (status asthmaticus), hyperkalemia
0.1 to 10 mcg/kg per minute IV/IO infusion; consider 10 mcg/kg IV/IO load over
5 minutes
10 mcg/kg subcutaneously q 10 to 15 minutes until IV/IO infusion is initiated (max
single dose 0.4 mg)
Vasopressin Cardiac arrest
0.4 to 1 unit/kg bolus (max 40 units)
Catecholamine-resistant hypotension
0.0002 to 0.002 unit/kg per minute (0.2 to 2 milliunits/kg per minute) continuous infusion
GRAY* PINK RED PURPLE YELLOW WHITE BLUE ORANGE GREEN
Equipment Small Infant Infant Toddler Small Child Child Child Large Child Adult
3-5 kg
6-7 kg 8-9 kg 10-11 kg 12-14 kg 15-18 kg 19-23 kg 24-29 kg 30-36 kg
Resuscitation
Infant/child Infant/child Child Child Child Child Child Adult
bag
Oral airway 50 50 60 60 60 70 80 80
(mm)
ET tube 3.5 Uncuffed 3.5 Uncuffed 4.0 Uncuffed 4.5 Uncuffed 5.0 Uncuffed 5.5 Uncuffed
6.0 Cuffed 6.5 Cuffed
(mm) 3.0 Cuffed 3.0 Cuffed 3.5 Cuffed 4.0 Cuffed 4.5 Cuffed 5.0 Cuffed
ET tube 3 kg 9-9.5
insertion 4 kg 9.5-10 10.5-11 10.5-11 11-12 13.5 14-15 16.5 17-18 18.5-19.5
length (cm) 5 kg 10-10.5
Suction 8 8 10 10 10 10 10 10-12
catheter (F)
Neonatal Infant/child Infant/child Child Child Child Child Child Small adult
BP cuff
#5/infant
IV catheter (ga) 22-24 22-24 20-24 18-22 18-22 18-20 18-20 16-20
Pediatric Color-Coded Length-Based
Chest tube (F) 10-12 10-12 16-20 20-24 20-24 24-32 28-32 32-38
Abbreviations: BP, blood pressure; ET, endotracheal; F, French; IO, intraosseous; IV, intravenous; NG, nasogastric; NRB, nonrebreathing.
*For Gray column, use Pink or Red equipment sizes if no size is listed.
Per 2010 AHA Guidelines, in the hospital cuffed or uncuffed tubes may by used (see below for sizing of cuffed tubes).
Adapted from Broselow™ Pediatric Emergency Tape. Distributed by Armstrong Medical Industries, Lincolnshire, IL. Copyright 2007 Vital Signs, Inc. All rights reserved.
Pediatric Cardiac Arrest Algorithm
Yes No
2 Rhythm shockable?
VF/VT 9 Asystole/PEA
3
Shock
4
CPR 2 min
IO/IV access
No
Rhythm shockable?
Yes
5
Shock
10
6 CPR 2 min
CPR 2 min
IO/IV access
Epinephrine every 3-5 min
Epinephrine every 3-5 min
Consider advanced airway
Consider advanced airway
No Yes
Rhythm shockable? Rhythm shockable?
Yes
7 Shock No
8 11
CPR 2 min CPR 2 min
Amiodarone Treat reversible causes
Treat reversible causes
No Yes
Rhythm shockable?
12
Asystole/PEA 10 or 11
Go to
Organized rhythm check pulse
5 or 7
Pulse present (ROSC) post cardiac arrest care
Doses/Details for the
Pediatric Cardiac Arrest Algorithm
Initial Impression
(consciousness, breathing, color)
Yes No
No
If at any time
you identify
cardiac arrest
Evaluate
Start CPR Primary assessment
(C-A-B) Secondary assessment
Diagnostic tests
Go to
Pediatric Cardiac Arrest Intervene
Algorithm
Identify
No Cardiopulmonary Cardiopulmonary
compromise Compromise
continues? Hypotension
Acutely altered mental
status
Yes Signs of shock
CPR if HR <60/min
with poor perfusion despite
oxygenation and ventilation
Support ABCs
Give oxygen No Bradycardia
Observe persists?
Consider expert
consultation
Yes
Doses/Details
Epinephrine
Epinephrine IO/IV Dose:
Atropine for increased vagal
0.01 mg/kg (0.1 mL/kg
tone or primary AV block of 1:10 000 concentration).
Consider transthoracic Repeat every 3-5 minutes.
pacing/transvenous pacing If IO/IV access not
Treat underlying causes available but endotracheal
(ET) tube in place, may
give ET dose: 0.1 mg/kg
(0.1 mL/kg of 1:1000).
Doses/Details
Identify and treat underlying cause
Synchronized
Maintain patent airway; assist breathing as necessary Cardioversion:
Oxygen Begin with 0.5-1
Cardiac monitor to identify rhythm; monitor blood J/kg; if not effective,
pressure and oximetry increase to 2 J/kg.
Sedate if needed,
IO/IV access
but don't delay
12-Lead ECG if available; don't delay therapy cardioversion.
Adenosine
Narrow Wide IV/IO Dose:
Evaluate First dose:
(<0.09 sec) (>0.09 sec)
0.1 mg/kg rapid
QRS bolus (maximum:
duration 6 mg). Second
Evaluate rhythm dose: 0.2 mg/kg
rapid bolus
with 12-lead ECG (maximum second
or monitor dose: 12 mg).
Amiodarone
IV/IO Dose:
5 mg/kg over
Probable Probable Possible 20-60 minutes
sinus supraventricular ventricular or
tachycardia tachycardia tachycardia Procainamide
IV/IO Dose:
Compatible Compatible history
15 mg/kg over
history (vague, nonspecific); 30-60 minutes
consistent with history of abrupt Do not routinely
known cause rate changes administer
P waves P waves absent/ amiodarone and
present/normal abnormal procainamide
Variable R-R; HR not variable together.
constant PR
Infants: Infants: rate usually Cardiopulmonary
rate usually >220/min compromise?
<220/min Hypotension No
Children: rate Children: rate Acutely altered
usually<180/min usually >180/min mental status
Signs of shock
Yes